SCHEMBL8165802

SCHEMBL8165802

Cc1ccc(S(=O)(=O)OC[C@H](O)[C@H](C)CCc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
LMNA P02545 1/20 0.41
CNR2 P34972 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MCHR1 Q99705 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 2/20 0.40
FKBP1A P62942 1/20 0.39
GAA P10253 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CA12 O43570 1/20 0.39
CYP3A4 P08684 1/20 0.39
ATM Q13315 1/20 0.39
CA9 Q16790 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8165807 1.00 ALDH1A1 (0.51) ALDH1A1LMNACNR2CYP1A2CYP2C9
SCHEMBL8165805 1.00 ALDH1A1 (0.51) ALDH1A1LMNACNR2CYP1A2CYP2C9
SCHEMBL2076248 0.86 ALDH1A1 (0.51) ALDH1A1LMNACNR2CYP1A2POLB
SCHEMBL2076247 0.86 ALDH1A1 (0.51) ALDH1A1LMNACNR2CYP1A2POLB
SCHEMBL2076249 0.86 ALDH1A1 (0.51) ALDH1A1LMNACNR2CYP1A2POLB
SCHEMBL4596569 0.83 ALDH1A1 (0.53) ALDH1A1CNR2CYP1A2CYP2C9CYP2C19
SCHEMBL6882711 0.81 ALDH1A1 (0.51) ALDH1A1CNR2CYP1A2CYP2C9CYP2C19
SCHEMBL13536697 0.80 CA2 (0.43) ALDH1A1LMNAKMT2AGAACA12
SCHEMBL1730532 0.79 STAT3 (0.46) ALDH1A1CYP2C9CYP2C19KMT2AGAA
SCHEMBL70900 0.79 STAT3 (0.46) ALDH1A1CYP2C9CYP2C19KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133457-A CRYPTOPHYCIN COMPOUNDS HAVING ANTIMICROTUBULE ACTIVITY; ANTIMETABOLITES ELI LILLY AND COMPANY (US) 2000-10-17 US disclosed
EP-0861839-A1 Selective epoxidation process for preparing cryptophycin compounds and intermediates ELI LILLY AND COMPANY (US) 1998-09-02 EP disclosed